BioCentury
ARTICLE | Clinical News

Tretten recombinant coagulation Factor XIII A-subunit regulatory update

January 6, 2014 8:00 AM UTC

On Dec. 23, 2013, FDA approved a resubmitted BLA from Novo Nordisk for Tretten recombinant coagulation Factor XIII A-subunit to prevent bleeding in patients with congenital Factor XIII A-subunit defic...